Form 4: HealthStream EVP O'Hara Granted Equity Awards

HealthStream's Executive Vice President, Kevin P. O'Hara, was granted 3,134 Restricted Share Units and 9,402 Employee Stock Options.

Summary

• Kevin P. O'Hara, Executive Vice President of HealthStream Inc. (HSTM), was granted equity awards on December 9, 2025.
• The awards include 3,134 Restricted Share Units (RSUs) and 9,402 Employee Stock Options.
• Each RSU represents the contingent right to receive one share of common stock upon vesting.
• The employee stock options have an exercise price of $23.93 and an expiration date of December 9, 2035.
• Both the RSUs and options are subject to a four-year vesting schedule, contingent on continued service: 15% vest on December 9, 2026, 20% on December 9, 2027, 30% on December 9, 2028, and the remaining 35% vest on December 9, 2029.
• Following these grants, O'Hara beneficially owns 16,373 shares of common stock directly (non-derivative).

Sentiment

Score: 7

Explanation: The grant of equity awards to a key executive is generally a positive signal, indicating management retention and alignment with shareholder interests. It's a routine compensation event, not indicative of extraordinary positive or negative news, hence a neutral-to-positive score.

Positives

• The grant of equity awards aligns management's interests with those of shareholders, incentivizing long-term performance and value creation.
• The four-year vesting schedule promotes executive retention and sustained commitment to the company's success.

Risks

• The vesting of RSUs and options is contingent upon continued service, meaning the executive must remain employed to realize the full value of the awards.
• The value of the stock options is dependent on the future market price of HealthStream's common stock exceeding the exercise price of $23.93.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the vesting schedule of the equity awards, which implies an expectation of continued executive service.

Industry Context

Equity grants, such as Restricted Share Units (RSUs) and stock options, are standard compensation practices in the technology and healthcare IT sectors to attract, retain, and motivate key executives. This grant is consistent with typical industry practices for executive incentive compensation.

Comparison to Industry Standards

• The use of a mix of Restricted Share Units (RSUs) and Employee Stock Options is a common practice in executive compensation across the technology and healthcare sectors, similar to companies like Cerner (now Oracle Health) or Veeva Systems, which often use performance-based equity to align executive incentives with long-term shareholder value.
• A four-year vesting schedule, with a graded vesting approach (15%, 20%, 30%, 35%), is a standard retention mechanism, comparable to vesting schedules seen at many publicly traded software and services companies.
• The exercise price of $23.93 for the options would typically be set at the market price on the grant date, which is a standard practice to ensure options are 'at-the-money' at issuance, incentivizing future stock price appreciation.

Related Party Transactions

• The equity grants to Kevin P. O'Hara, an Executive Vice President, represent a form of compensation from the company to a key management member, which is a common related-party transaction in the context of executive remuneration.

Stakeholder Impact

• Shareholders: The equity grants align the executive's long-term interests with shareholder value creation, potentially leading to improved performance and stock appreciation.
• Employees: The grants demonstrate the company's commitment to retaining key talent, which can positively influence overall employee morale and stability.

Next Steps

• The RSUs will convert to common stock upon their respective vesting dates, contingent on continued service.
• The employee stock options will become exercisable on their respective vesting dates and can be exercised until their expiration date of December 9, 2035.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation grant to an executive. While it aligns management incentives with shareholder interests, it does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It's a standard event for executive retention and motivation.

Keywords

HealthStream, HSTM, SEC Form 4, Insider Transaction, Equity Grant, Restricted Share Units, Stock Options, Executive Compensation, Kevin O'Hara